Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04301258 · ClinicalTrials.gov registry record
ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry
A clinical trial, sponsored by AlloSource.
- Terminated
- Registry status
- 48
- Enrollment target
NCT04301258: Clinical Trial study, sponsored by AlloSource.
NCT04301258 is a clinical trial that was terminated before completion, run by AlloSource. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04301258 was terminated before completion, sponsored by AlloSource.
- TERMINATED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in cartilage repair procedures of the knee, ankle, foot and hip.
Primary Outcome
Obtain long-term results on patients who have undergone an articular cartilage repair procedure using ProChondrix CR, as assessed by patient reported outcomes.
Interventions
- OTHER Articular cartilage repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2023-09-14 |
Why NCT04301258 stopped before completion
NCT04301258 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Articular cartilage repair is the first listed.
NCT04301258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04301258 about?
NCT04301258 is a clinical study titled "ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry". The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in cartilage repair procedures of the knee, ankle, foot and hip.
What is the current status of trial NCT04301258?
This trial is currently terminated. The enrollment target is 48 participants. The study started on 2020-01-06. Estimated completion is 2023-09-14.
What interventions are being tested in trial NCT04301258?
The interventions under investigation include: Articular cartilage repair (OTHER).
Who is sponsoring clinical trial NCT04301258?
This trial is sponsored by AlloSource, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI